HowardYLiMD

Critical Care Medicine, Pleural Disease

Deputy Chief of Pulmonary and Critical Care Medicine

Dr. Li is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2010
University of ColoradoResidency, Internal Medicine, 2002 - 2006
Vanderbilt University School of MedicineClass of 2002

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers Start of enrollment: 2019 Jan 30
Active, not recruiting
Phase 2
Oral Iloprost for the Prevention of Lung Cancer In Former Smokers Start of enrollment: 2024 Jun 01
Withdrawn
Phase 2
Roles: Contact, Principal Investigator

PubMed

METTL3 alters capping enzyme expression and its activity on ribosomal proteins.
Daniel Del Valle-Morales, Giulia Romano, Giovanni Nigita, Michela Saviana, Alessandro La Ferlita
Scientific Reports. 2024-11-12
2 citations
HIF-2α-dependent induction of miR-29a restrains T1 activity during T cell dependent colitis.
Agnieszka K Czopik, Eóin N McNamee, Victoria Vaughn, Xiangsheng Huang, In Hyuk Bang
Nature Communications. 2024-09-14
1 citations
METTL3 alters capping enzyme expression and its activity on ribosomal proteins.
Daniel Del Valle-Morales, Giulia Romano, Patricia Le, Michela Saviana, Rachel Brown
Biorxiv. 2023-11-22